218 related articles for article (PubMed ID: 9598826)
41. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
[TBL] [Abstract][Full Text] [Related]
42. Urokinase and its receptors in chronic kidney disease.
Zhang G; Eddy AA
Front Biosci; 2008 May; 13():5462-78. PubMed ID: 18508599
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
[TBL] [Abstract][Full Text] [Related]
44. Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies.
Rønne E; Høyer-Hansen G; Brünner N; Pedersen H; Rank F; Osborne CK; Clark GM; Danø K; Grøndahl-Hansen J
Breast Cancer Res Treat; 1995 Mar; 33(3):199-207. PubMed ID: 7749147
[TBL] [Abstract][Full Text] [Related]
45. Urokinase binding and receptor identification in cultured endothelial cells.
Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM
J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968
[TBL] [Abstract][Full Text] [Related]
46. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor.
Masucci MT; Pedersen N; Blasi F
J Biol Chem; 1991 May; 266(14):8655-8. PubMed ID: 1851152
[TBL] [Abstract][Full Text] [Related]
47. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
48. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes.
Sitrin RG; Todd RF; Mizukami IF; Gross TJ; Shollenberger SB; Gyetko MR
Blood; 1994 Aug; 84(4):1268-75. PubMed ID: 8049441
[TBL] [Abstract][Full Text] [Related]
49. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Shetty S; Kumar A; Idell S
Mol Cell Biol; 1997 Mar; 17(3):1075-83. PubMed ID: 9032234
[TBL] [Abstract][Full Text] [Related]
50. Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators.
Yoshida E; Tsuchiya K; Sugiki M; Sumi H; Mihara H; Maruyama M
Inflammation; 1996 Jun; 20(3):319-26. PubMed ID: 8796383
[TBL] [Abstract][Full Text] [Related]
51. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
[TBL] [Abstract][Full Text] [Related]
52. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.
Møller LB; Pöllänen J; Rønne E; Pedersen N; Blasi F
J Biol Chem; 1993 May; 268(15):11152-9. PubMed ID: 8388383
[TBL] [Abstract][Full Text] [Related]
53. Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.
Behrendt N; Ronne E; Dano K
J Biol Chem; 1996 Sep; 271(37):22885-94. PubMed ID: 8798468
[TBL] [Abstract][Full Text] [Related]
54. Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane.
Bastholm L; Nielsen MH; De Mey J; Danø K; Brünner N; Høyer-Hansen G; Rønne E; Elling F
Biotech Histochem; 1994 Mar; 69(2):61-7. PubMed ID: 7515699
[TBL] [Abstract][Full Text] [Related]
55. Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity.
Riittinen L; Limongi P; Crippa MP; Conese M; Hernandez-Marrero L; Fazioli F; Blasi F
FEBS Lett; 1996 Feb; 381(1-2):1-6. PubMed ID: 8641412
[TBL] [Abstract][Full Text] [Related]
56. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
Graziano F; Elia C; Laudanna C; Poli G; Alfano M
PLoS One; 2011; 6(8):e23674. PubMed ID: 21858203
[TBL] [Abstract][Full Text] [Related]
57. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
[TBL] [Abstract][Full Text] [Related]
58. Characterization of urokinase receptor expression by human placental trophoblasts.
Zini JM; Murray SC; Graham CH; Lala PK; Karikó K; Barnathan ES; Mazar A; Henkin J; Cines DB; McCrae KR
Blood; 1992 Jun; 79(11):2917-29. PubMed ID: 1316787
[TBL] [Abstract][Full Text] [Related]
59. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
Cubellis MV; Nolli ML; Cassani G; Blasi F
J Biol Chem; 1986 Dec; 261(34):15819-22. PubMed ID: 3023326
[TBL] [Abstract][Full Text] [Related]
60. Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia.
Hayden SM; Seeds NW
J Neurosci; 1996 Apr; 16(7):2307-17. PubMed ID: 8601810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
